A one-stop microfluidic-based lung cancer organoid culture platform for testing drug sensitivity
Microfluidic devices as translational research tools provide a potential alternative to animal
experiments due to their ability to mimic physiological parameters. Several approaches that …
experiments due to their ability to mimic physiological parameters. Several approaches that …
Microfluidic organoids-on-a-chip: Quantum leap in cancer research
Simple Summary Organoids, also known as self-organized 3D organ-like clusters, represent
almost a physiological system for studying cells, stem cells, tissues, and diseases, especially …
almost a physiological system for studying cells, stem cells, tissues, and diseases, especially …
Engineering microfluidic organoid-on-a-chip platforms
In vitro cell culture models are emerging as promising tools to understand human
development, disease progression, and provide reliable, rapid and cost-effective results for …
development, disease progression, and provide reliable, rapid and cost-effective results for …
Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids
Abstract Three-dimensional (3D) cell culture technologies, such as organoids, are
physiologically relevant models for basic and clinical applications. Automated microfluidics …
physiologically relevant models for basic and clinical applications. Automated microfluidics …
Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week
Y Hu, X Sui, F Song, Y Li, K Li, Z Chen, F Yang… - Nature …, 2021 - nature.com
While the potential of patient-derived organoids (PDOs) to predict patients' responses to anti-
cancer treatments has been well recognized, the lengthy time and the low efficiency in …
cancer treatments has been well recognized, the lengthy time and the low efficiency in …
Application of a microfluidic chip-based 3D co-culture to test drug sensitivity for individualized treatment of lung cancer
Z Xu, Y Gao, Y Hao, E Li, Y Wang, J Zhang, W Wang… - Biomaterials, 2013 - Elsevier
Individualized treatment is a promising clinical strategy for lung cancer, and drug sensitivity
testing is fundamental to this scheme. We aimed to develop an effective drug sensitivity test …
testing is fundamental to this scheme. We aimed to develop an effective drug sensitivity test …
Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening
The recent advent of robust methods to grow human tissues as 3D organoids allows us to
recapitulate the 3D architecture of tumors in an in vitro setting and offers a new orthogonal …
recapitulate the 3D architecture of tumors in an in vitro setting and offers a new orthogonal …
[HTML][HTML] Tumor organoids as a pre-clinical cancer model for drug discovery
Tumor organoids are 3D cultures of cancer cells that can be derived on an individual patient
basis with a high success rate. This creates opportunities to build large biobanks with …
basis with a high success rate. This creates opportunities to build large biobanks with …
Non-small cell lung carcinoma spheroid models in agarose microwells for drug response studies
Q Luan, JH Becker, C Macaraniag, MG Massad… - Lab on a Chip, 2022 - pubs.rsc.org
There is a growing interest in developing personalized treatment strategies for each cancer
patient, especially those with non-small cell lung carcinoma (NSCLC) which annually …
patient, especially those with non-small cell lung carcinoma (NSCLC) which annually …
Organoid cultures as preclinical models of non–small cell lung cancer
R Shi, N Radulovich, C Ng, N Liu, H Notsuda… - Clinical Cancer …, 2020 - AACR
Purpose: Non–small cell lung cancer (NSCLC) is the most common cause of cancer-related
deaths worldwide. There is an unmet need to develop novel clinically relevant models of …
deaths worldwide. There is an unmet need to develop novel clinically relevant models of …